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Correspondence The Incidence and Clinical Outcome of ConstrictivePhysiology After Coronary Artery Bypass Graft SurgeryTo the Editor: Previous reports have shown changes in the etio-
logic spectrum of constrictive pericarditis, characterized mainly by
a declining incidence of tuberculous pericarditis and an increase in
cases resulting from cardiac surgery (1). Constrictive physiology
(CP) not only is found in patients with symptomatic constrictive
pericarditis but is also more commonly observed in post-cardiac
surgery patients when assessed with comprehensive echocardio-
graphic examination. However, few data are available with regard
to echocardiographically observed post-operative CP. Therefore,
the purpose of this study was to investigate the incidence and
clinical course of CP observed on post-operative echocardiographic
examination in patients who had undergone isolated coronary
artery bypass graft (CABG) surgery.
Our study population consisted of 454 consecutive patients who
underwent isolated CABG with comprehensive pre- and post-
operative transthoracic echocardiography (TTE) at the Severance
Cardiovascular Hospital from 2004 to 2006. The patients were
divided into 2 groups (the CP group vs. the No-CP group)
according to the presence or absence of the following CP findings
on post-operative TTE (2): abnormal ventricular septal motion,
dilated inferior vena cava, typical respiratory variations in mitral or
hepatic venous flow, and preserved or exaggerated early diastolic
mitral annular velocity.
Seventy-eight (17%) of 454 patients showed CP on post-
operative TTE (Table 1). In the CP group, no patient showed
right ventricular dysfunction, and 5 patients (6%) showed severe
tricuspid regurgitation. There were no significant differences in
preoperative baseline characteristics between the 2 groups. How-
ever, on post-operative TTE, which was conducted a median of 7
days (interquartile range [IQR]: 6 to 9 days) after CABG in the
CP group and a median of 7 days (IQR: 6 to 9 days) after CABG
in the No-CP group (p  0.863), left ventricular ejection fraction
(LVEF) was higher (59  12% vs. 55  13%, p  0.030), and the
requency of regional wall motion abnormality was lower (36%
s. 51%, p  0.019) in the CP group. Also, pericardial effusion
n TTE was more commonly observed in the CP group (39%
s. 19%, p 0.001). Cardiac multi-detector computed tomog-
raphy (MDCT) was performed within 1 month after CABG to
assess immediate graft patency if possible. Of the patients who
performed MDCT, the rate of graft patency and pericardial
thickening were similar between the 2 groups. There were no
significant differences of post-operative clinical symptoms—
including dyspnea, chest pain, peripheral edema, or fever—
between both groups.
Multivariate logistic regression analysis was performed to iden-
tify factors independently associated with post-operative CP
(Table 1). Variables with p value 0.100 from univariate analysis
were included in multivariate analysis. However, pre-operative
TTE parameters were excluded to avoid collinearity problems with
corresponding post-operative TTE values. The presence of post-operative pericardial effusion was independently associated with
post-operative CP (odds ratio: 2.64, 95% confidence interval [CI]:
1.52 to 4.58, p  0.001).
During follow-up (614  357 days vs. 623  292 days after
CABG, p  0.802), the rates of composite clinical events including
heart failure, death due to heart failure, constrictive pericarditis, or
cardiac tamponade were not different between both groups by the
log-rank test (6.0% vs. 4.4%, p  0.325) (Fig. 1A, Table 1).
Sixty-one patients (78%) of the CP group underwent follow-up
TTE (Fig. 1B). Of them, 50 (82%) showed complete resolution of
CP a median of 466 days (IQR: 244 to 738 days) after CABG.
The other 11 (18%) still showed residual CP until the last
follow-up TTE, which was conducted a median of 757 days (IQR:
78 to 1,142 days) after CABG. Of these 11 patients, only 1
progressed to clinically symptomatic constrictive pericarditis with
symptoms of dyspnea, engorged jugular veins, friction rub, and
thickened pericardium on MDCT. The remaining 10 patients did
not have any of these features.
Our study showed that post-operative CP is a relatively com-
mon finding (17% after CABG) compared with typical constrictive
pericarditis, which is a well-recognized but rare complication after
CABG, occurring in 0.2% to 0.3% of patients (3). Comprehensive
TTE have contributed significantly to the ability of physicians to
easily and reliably detect CP without invasive catheterization or
operative findings.
Matsuyama et al. (4) suggested that post-operative pericardial
effusion and normal LVEF are predictors of constrictive pericar-
ditis after CABG. They explained that there is continuous violent
friction between the pericardium and the beating heart under
normal LVEF. This friction can potentially result in pericardial
injury, inflammation, and pericarditis. Our study showed similar
findings. Post-operative pericardial effusion was identified as a
predictor of post-operative CP. In addition, post-operative left
ventricular systolic function was more preserved in the CP group
by univariate analysis. These findings might explain the role of
pericardial friction and resultant pericardial inflammation in the
pathogenesis of post-operative CP. Although C-reactive protein
and erythrocyte sedimentation rate values during post-operative
period were available only in 11 patients of the CP group, all of
them had elevated C-reactive protein (7.6  5.9 mg/dl, reference
range: 0 to approximately 0.8 mg/dl) and erythrocyte sedimen-
tation rate (62  34 mm/h, reference range: 0 to approximately
15 mm/h).
Most (82%) patients in the CP group showed complete reso-
lution of CP. Only 1 (1%) patient progressed to constrictive
pericarditis. Furthermore, clinical event rates of the CP group and
the No-CP group were similar during follow-up. These findings
support the transient and benign nature of post-operative CP.
Because CABG is a traumatic procedure with intraoperative
irritation to the pericardium by the physical manipulation of
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cardial friction can possibly cause pericardial inflammation, which
is enough to cause transient CP but not enough to cause constric-
tive pericarditis. No patient in the CP group showed irreversible
pericardial adhesion, fibrosis, or calcification on MDCT. These
findings might also explain the transient and benign nature of
post-operative CP.
Although follow-up echocardiography was recommended in all
patients, 17 (22%) patients with post-operative CP did not have
Characteristics of the 2 GroupsTable 1 Charact ristics of the 2 Groups
Univariate A
CP Group
(n  78)
No-CP
(n 
Pre-operative period
Age, yrs 62.2 8.3 62.7
Men 59 (76%) 265 (7
Smoking history 42 (54%) 164 (4
Diabetes mellitus 29 (37%) 154 (4
LVEF, % 59 12 56
RWMA 32 (41%) 196 (5
Pericardial effusion on TTE 1 (1%) 12 (3
Off-pump CABG 55 (70%) 300 (8
Post-operative period
LVEF, % 59 12 55
RWMA 28 (36%) 190 (5
Pericardial effusion on TTE 30 (39%) 71 (1
Newly developed atrial fibrillation 3 (4%) 19 (5
Low voltage QRS 13 (17%) 28 (7
Beta blocker 59 (76%) 263 (7
Patent graft on MDCT 57 (89%) 243 (8
Pericardial thickening on MDCT 3 (5%) 4 (1
Clinical symptoms* 14 (18%) 39 (1
Follow-up duration, days after CABG 614 357 623
Composite of clinical events† 4 (6.0%) 12 (4
Values are mean  SD or n (%). *Include dyspnea, chest pain, peripheral edema, or fever; †includ
the log-rank test.
CABG  coronary artery bypass graft; CI  confidence interval; CP  constrictive physiology; LV
all motion abnormality; TTE  transthoracic echocardiography.
Figure 1 Kaplan-Meier Survival Curves and Follow-Up of Post-Operative
(A) Kaplan-Meier survival curves. Comparison of composite clinical event-free surv
(B) Follow-up of post-operative CP. Clinical course of post-operative CP during the
TTE  transthoracic echocardiography.serial follow-up TTE for various reasons. Another limitation is
small sample size. However, to the best of our knowledge, this is
the first study investigating the incidence and clinical outcome of
post-operative CP.
Post-operative CP is relatively common in patients who under-
went CABG. However, it is usually transient and benign. Pro-
gression to clinically symptomatic permanent constrictive pericar-
ditis is rare. Therefore, conservative management might be
warranted for post-operative CP.
is Multivariate Analysis
p Value
Odds
Ratio 95% CI
p
Value
0.570
0.359
0.099 1.58 0.94–2.66 0.082
0.536
0.118
0.074
0.707
0.071 0.69 0.38–1.24 0.215
0.030 1.01 0.99–1.04 0.297
0.019 1.68 0.85–3.30 0.134
0.001 2.64 1.52–4.58 0.001
1.000
0.010
0.314
0.717
0.124
0.058
0.802
0.325‡
failure, death due to heart failure, constrictive pericarditis, or cardiac tamponade; ‡calculated by
ft ventricular ejection fraction; MDCT  multi-detector computed tomography; RWMA  regional
rves between the constrictive physiology (CP) group and No-CP group.
up period. CABG  coronary artery bypass graft surgery;nalys
Group
376)
8.2
1%)
4%)
1%)
15
2%)
%)
0%)
13
1%)
9%)
%)
%)
0%)
7%)
%)
0%)
292
.4%)
e heartCP
ival cu
follow-
mp
w
i
g
6
H
r
(
b
s
r
a
s
m
a
v
R
2112 Correspondence JACC Vol. 61, No. 20, 2013
May 21, 2013:2110–4Eui Im, MD†
Chi Young Shim, MD, PhD†
Geu-Ru Hong, MD†
Kyung-Jong Yoo, MD‡
Young-Nam Youn, MD‡
Byung-Chul Chang, MD, PhD‡
Yangsoo Jang, MD, PhD†
Namsik Chung, MD, PhD†
*Jong-Won Ha, MD, PhD†
*Division of Cardiology
Severance Biomedical Science Institute
Yonsei University College of Medicine
134 Shinchon-dong
Seodaemun-gu
Seoul 120-752
Republic of Korea
E-mail: jwha@yuhs.ac
http://dx.doi.org/10.1016/j.jacc.2013.02.033
From the †Division of Cardiology, Severance Biomedical
Science Institute, Yonsei University College of Medicine,
Seoul, Republic of Korea; and the ‡Division of Cardiovascular
Surgery, Severance Biomedical Science Institute, Yonsei University
College of Medicine, Seoul, Republic of Korea.
Please note: This work was supported by a Korea Science and Engineering Foundation grant
funded by the Korean government (M10642120001-06N4212-00110). The authors have
reported that they have no relationships relevant to the contents of this paper to disclose.
REFERENCES
1. Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the
modern era: evolving clinical spectrum and impact on outcome after
pericardiectomy. Circulation 1999;100:1380–6.
2. Ha JW, Oh JK, Ommen SR, Ling LH, Tajik AJ. Diagnostic value of mitral
annular velocity for constrictive pericarditis in the absence of respiratory
variation in mitral inflow velocity. J Am Soc Echocardiog 2002;15:1468–71.
3. Fowler NO. Constrictive pericarditis: its history and current status. Clin
Cardiol 1995;18:341–50.
4. Matsuyama K, Matsumoto M, Sugita T, et al. Clinical characteristics of
patients with constrictive pericarditis after coronary bypass surgery. Jpn
Circ J 2001;65:480–2.
Letters to the Editor
Predictive Value of
6-Min Walk Test Distance
Versus Cardiopulmonary
Exercise Testing in Systolic
Heart Failure
Same Value for Different Approaches?
The study by Forman et al. (1) increases the perspectives on how
the distance of the 6-min walk test (6MWT) and the measuredoxygen uptake (VO2) and ventilatory efficiency (VE/VCO2 slope)
ay add to the prognostic workup of heart failure (HF) patients.
By examining these variables in a mild-to-moderate risk HF
opulation, a similar prediction for hospitalization and mortality
as observed at univariate analysis, whereas no prognostic discrim-
nation emerged when variables were tested against main demo-
raphic and clinical characteristics.
Findings are relevant because they definitively strengthen the
MWT as a simple test that quantitatively mirrors the severity of
F syndrome. The question is whether this further evidence may
estrain clinicians from performing a cardiopulmonary exercise test
CPET) that would not add to the prognostic indications provided
y a 6MWT, obviously opting for cost-effectiveness and avoiding
ome complexity related to a CPET.
We believe that a few considerations may help to critically
econsider this conceivable but perhaps simplistic conclusion,
nticipating future directions in pre-specified trials.
Over the past 10 years, survival studies of CPET in HF and
tatements (2) have defined how an approach that includes
ultiple variables would better define prognosis based on the
ssumption that exercise limitation is multifactorial and any single
ariable may only partially reflect the complex pathophysiology.
Peak VO2 and VE/VCO2 slope are strong predictive variables,
but it seems important to question how the present findings would
have been changed if, for example, the presence of the exercise
oscillatory ventilation (EOV) pattern, which has been consistently
proven prognostically superior to both peak VO2 and VE/VCO2
slope, or the oxygen efficiency slope, had been included in the
statistical model. EOV clearly outperformed the 6MWT distance
in a previous report (3).
Addressing the role of different exercise modalities by using a
multiparametric approach that may truly reflect the whole poten-
tiality of each test will probably provide a balanced view on how
6MWT distance and CPET are equal or when each test may provide
better value in the risk stratification among HF populations.
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